Fabrication of Biocompatible, Luminescent Supramolecular Structures and Their Applications in the Detection of Dopamine

Gold Nanocluster-Encapsulated Hyperbranched Polyethyleneimine for Selective and Ratiometric Dopamine Analyses by Enhanced Self-Polymerization

The exploitation of selective and sensitive dopamine (DA) sensors is essential to more deeply understand its biological function and diagnosis of related diseases. In this study, gold nanocluster-encapsulated hyperbranched polyethyleneimine (hPEI-Au NCs) has been explored as the specific and ratiometric DA nanoprobe through hPEI-assisted DA self-polymerization reactions. The Au NCs encapsulation not only provides a fluorescent internal reference but also enhances the DA self-polymerization by weakening the proton sponge effect of the hPEI layer. Rapid and sensitive DA detection is realized through the proposed hPEI-Au NC nanoprobe with a limit of detection of 10 nM. The favorable selectivity over other possible interferents including amino acids, sugars, and salts is due to the specific self-polymerization reaction. The DA analysis in urine samples with small relative standard deviations has been accomplished with an hPEI-Au NC nanoprobe.

Advances in nanomedicines for diagnosis of central nervous system disorders

In spite of a great improvement in medical health services and an increase in lifespan, we have witnessed a skyrocket increase in the incidence of central nervous system (CNS) disorders including brain tumors, neurodegenerative diseases (Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease), ischemic stroke, and epilepsy, which have seriously undermined the quality of life and substantially increased economic and societal burdens. Development of diagnostic methods for CNS disorders is still in the early stage, and the clinical outcomes suggest these methods are not ready for the challenges associated with diagnosis of CNS disorders, such as early detection, specific binding, sharp contrast, and continuous monitoring of therapeutic interventions. Another challenge is to overcome various barrier structures during delivery of diagnostic agents, especially the blood-brain barrier (BBB). Fortunately, utilization of nanomaterials has been pursued as a potential and promising strategy to address these challenges. This review will discuss anatomical and functional structures of BBB and transport mechanisms of nanomaterials across the BBB, and special emphases will be placed on the state-of-the-art advances in the development of nanomedicines from a variety of nanomaterials for diagnosis of CNS disorders. Meanwhile, current challenges and future perspectives in this field are also highlighted.

A high-performance fluorescent probe for dopamine detection based on g-C3N4 nanofibers

A novel fluorescent sensor based on g-C₃N₄ nanofibers for the sensitive detection of dopamine (DA) has been proposed. We synthesized g-C₃N₄ nanofibers by directly hydrolyzing bulk g-C₃N₄ in the alkaline atmosphere (3 M NaOH). The obtained ultrathin g-C₃N₄ nanofibers were verified by characterizations of Transmission electronic microscope (TEM), X-ray diffractometer (XRD), Fourier transformation-infrared (FT-IR) and X-ray photoelectron spectroscopy (XPS). It was found that the fluorescence intensity of g-C₃N₄ nanofibers was obviously quenched by DA. Fluorescence resonance energy transfer (FRET) between DA and g-C₃N₄ nanofibers led to the fluorescence reduction of g-C₃N₄ nanofibers. The fluorescent probe based on g-C₃N₄ nanofibers exhibits linear responses to the concentration of DA in the range from 0 to 4 μM and 4 to 20 μM, the limit of detection is 17 nM. The fluorescent probe shows excellent stability, good selectivity with its application in serums.